Nombre del producto:3-[4-({[(2-bromophenyl)methyl]carbamoyl}methyl)-3-oxo-3,4-dihydroquinoxalin-2-yl]-N-(2-methylpropyl)propanamide

IUPAC Name:3-[4-({[(2-bromophenyl)methyl]carbamoyl}methyl)-3-oxo-3,4-dihydroquinoxalin-2-yl]-N-(2-methylpropyl)propanamide

CAS:1251615-34-5
Fórmula molecular:C24H27BrN4O3
Pureza:95%+
Número de catálogo:CM856062
Peso molecular:499.41

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1251615-34-5
Fórmula molecular:C24H27BrN4O3
Punto de fusión:-
Código de sonrisas:CC(C)CNC(=O)CCC1=NC2=C(C=CC=C2)N(CC(=O)NCC2=C(Br)C=CC=C2)C1=O
Densidad:
Número de catálogo:CM856062
Peso molecular:499.41
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.